Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia

Reproductive Sciences

Volumn 20, Issue 1, 2013, Pages 45-50

  Ismail, Mohamed Taha ^a   Fahmy, Dalia M ^b   Elshmaa, Nagat S ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c TANTA UNIVERSITY   (Egypt)

Author keywords

levonorgestrel releasing intrauterine system; progestins; simple endometrial hyperplasia

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; KUWAIT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; ENDOMETRIAL HYPERPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; PROGESTINS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84870482617     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112459243     Document Type: Article

References (14)

1. Hannemann MM, Alexander MH, Cope JN, Acheson N, Phillips A. Endometrial hyperplasia: a clinician's review. Obstet Gynecol Reprod Med. 2010 ; 20 (4). 116-120
2. Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv. 2004 ; 59 (5). 368-378
3. Amezcua CA, Lu JJ, Felix JC, Stanczyk FZ, Zheng W. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Gynecol Oncol. 2000 ; 79 (2). 169-176
4. Brache V, Faundes A, Alvarez F, Cochon L. Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception. 2002 ; 65 (1). 63-74
5. Rattanachaiyanont M, Angsuwathana S, Techatrisak K, Tanmahasamut P, Indhavivadhana S, Leerasiri P. Clinical and pathological responses of progestin therapy for non-Atypical endometrial hyperplasia: a prospective study. J Obstet Gynaecol Res. 2005 ; 31 (2). 98-106
6. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA. 2004 ; 291 (12). 1456-1463
7. Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin Endocrinol. 1982 ; 17 (6). 529-536
8. Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clins N Am. 2007 ; 34 (4). 717-737
9. Wheeler DT, Bristow RE, Kurman RJ. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol. 2007 ; 31 (7). 988-998
10. Ørbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008 ; 111 (1). 68-73
11. Vereide AB, Arnes M, Straume B, Maltau JM, Orbo A. Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone. Gynecol Oncol. 2003 ; 91 (3). 526-533
12. Ozdegirmenci O, Kayikcioglu F, Bozkurt U, Akgul MA, Haberal A. Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia. Gynecol Obstet Invest. 2011 ; 72 (1). 10-14
13. Bese T, Vural A, Ozturk M, et al. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia. Int J Gynecol Cancer. 2006 ; 16 (2). 809-813
14. Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol. 1989 ; 160 (1). 126-131